---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-027816"
form_type: "8-K"
ticker: "PRME"
cik: "0001894562"
company_name: "Prime Medicine, Inc."
filed_at: "2024-06-12T23:59:59+00:00"
generated_at: "2026-06-01T04:55:38.848330+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Prime Medicine stockholders elect directors, approve officer liability limitation

## Summary
- Stockholders elected Wendy Chung, Kaye Foster, Keith Gottesdiener, and Jeffrey Marrazzo as Class II directors.
- Approved certificate amendment to limit officer liability as permitted by Delaware law with 91.5M votes for.
- Ratified PricewaterhouseCoopers as independent auditor for FY2024 with 106.9M votes for.
- Annual meeting held June 12, 2024; quorum of 107.1M shares represented.
- All proposals passed; no dissident activity or unexpected vote outcomes.

## SEC filing metadata
- accession: 0001628280-24-027816
- form_type: 8-K
- ticker: PRME
- cik: 0001894562
- company_name: Prime Medicine, Inc.
- filed_at: 2024-06-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1894562/000162828024027816/0001628280-24-027816-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1894562/000162828024027816/prme-20240612.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-027816
- JSON: https://secwatch.observer/filing/0001628280-24-027816.json
- Plain text: https://secwatch.observer/filing/0001628280-24-027816.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.